Monix Health is a Swiss medical device company building a wearable patch for continuous, painless hormonal monitoring, starting with IVF. The patch uses aptamer-based electrochemical biosensors and a microneedle array to read key reproductive hormones (LH and progesterone now; estradiol and FSH next) from interstitial fluid every 10 minutes, replacing 5-14 blood draws per cycle with thousands of real-time readings. We sell to IVF clinics on a per-cycle basis, with an app subscription for patients and a third revenue layer from de-identified longitudinal data. IVF is a USD 35B market and the wedge into a 1B+ woman hormonal-health platform (PCOS, endometriosis, pregnancy, menopause). Class 2a MDR / FDA 510(k). 12 LOIs across 9 countries; CHF 1.5M raised; CHF 6M Seed closing December 2026.
No news
30.04.2026
CSEM technology collaboration: Milestone 1 delivered on time
30.04.2026
Device engineering complete
31.03.2026
Progesterone aptamer development complete
31.03.2026
LH detection validated in vitro at clinically relevant concentrations
31.03.2026
Device regulatory classification finalized: FDA 510(k) + EU MDR Class IIa
No Jobs
Snäx Fridge
No Awards
Website:
www.monix.health
Headquarter:
Allschwil
Foundation Date:
July 2025
Technology:
Sectors: